Skip to main content
Sartorius Stedim Biotech logo

Sartorius Stedim Biotech — Investor Relations & Filings

Ticker · DIM ISIN · FR0013154002 LEI · 52990006IVXY7GCSSR39 PA Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2025-03-05 Declaration of Voting R…
Country FR France
Listing PA DIM

About Sartorius Stedim Biotech

https://www.sartorius.com/en

Sartorius Stedim Biotech is a leading international provider of equipment and services for the biopharmaceutical industry. The company offers integrated solutions that support the entire lifecycle of drug development and manufacturing, from research and development to quality assurance and commercial production. Its comprehensive portfolio includes technologies for filtration, fluid management, fermentation, cell culture, and purification. Key products encompass bioreactors, single-use systems, process filtration equipment, cell culture media, and data analytics software. Sartorius Stedim Biotech enables its customers to develop and manufacture biotech medications, including cell and gene therapies, more efficiently and safely, helping to accelerate the translation of scientific discoveries into patient care.

Recent filings

Filing Released Lang Actions
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL" and provides a specific table detailing the total number of shares and voting rights as of February 28, 2025. This type of mandatory disclosure, often related to Article L 233-8-II of the French Code of commerce and AMF regulations, concerns the company's capital structure and voting power. This fits best under the category related to capital structure changes or mandatory regulatory disclosures. While it touches upon capital, it is specifically a declaration of the current share/voting rights count. This is a specific regulatory filing. Reviewing the definitions, it is not a standard 10-K, ER, or IR. It is a specific regulatory announcement. The closest fit among the provided codes for a declaration of voting rights/share capital count is not explicitly listed, but it is a mandatory regulatory filing. Given the content (declaration of total shares and voting rights), it is a specific type of regulatory update. Since there is no specific code for 'Share Capital Declaration', I must choose the most appropriate category. It is not a Director's Dealing (DIRS), Dividend (DIV), or Share Issue (SHA/POS). It is a mandatory regulatory filing disseminated via EQS News Service. The category 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)'. This document is a declaration of the *current* total voting rights, not the *results* of a vote. Therefore, the most appropriate fallback for a specific, non-standard regulatory disclosure is 'Regulatory Filings' (RNS).
2025-03-05 English
Sartorius Stedim Biotech SA: Information on Document Availability
Report Publication Announcement Classification · 1% confidence The document is a short regulatory news release dated February 17, 2025, titled "Sartorius Stedim Biotech SA: Information on Document Availability." It explicitly states that the 'Sartorius Stedim Biotech Group’s Universal Registration Document 2024' is now available and provides a link to access it. The document length is very short (3390 characters). According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and announces the availability of a full report (like the Universal Registration Document, which often contains the 10-K equivalent information), it should be classified as a Report Publication Announcement (RPA). The AMF Category listed also mentions 'Terms of availability of the annual financial report,' reinforcing this conclusion.
2025-02-18 English
Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents
Report Publication Announcement Classification · 1% confidence The document is a short press release (1675 characters) titled 'Communiqué de mise à disposition de documents' (Press release regarding the availability of documents). It informs shareholders that the 2024 Universal Registration Document is available via a provided URL. Per the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-02-17 French
Sartorius Stedim Biotech SA: Information on Document Availability
Report Publication Announcement Classification · 1% confidence The document is a short press release (1562 characters) that explicitly states the 'Universal Registration Document 2024 is now available' at a provided URL. It does not contain the full report itself, but rather serves as a notification of its publication and availability. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-02-17 English
Sartorius Stedim Biotech SA: Information on Document Availability
Report Publication Announcement Classification · 1% confidence The document is a short regulatory news release dated February 17, 2025, titled "Sartorius Stedim Biotech SA: Information on Document Availability." The core content explicitly states that the 'Sartorius Stedim Biotech Group’s Universal Registration Document 2024' (which contains the annual financial statements for the year ended December 31, 2024) is now available and provides a link to access it. According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and merely announces the publication or availability of a full report (like an Annual Report or 10-K), it should be classified as a Report Publication Announcement (RPA). The AMF Category listed also mentions 'Terms of availability of the annual financial report,' reinforcing this is an announcement about the report, not the report itself.
2025-02-17 English
Sartorius Stedim Biotech releases Universal Registration Document 2024
Report Publication Announcement Classification · 1% confidence The document is a short news release dated February 17, 2025, announcing that 'Sartorius Stedim Biotech releases Universal Registration Document 2024 including the Annual Financial Report.' It explicitly provides a link to the document and does not contain the full content of the Annual Report or the Annual Financial Report itself. According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of a report, it should be classified as a Report Publication Announcement (RPA). The mention of the 'Annual Financial Report' suggests the underlying document is comprehensive, but this specific filing is merely the announcement of its availability.
2025-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.